您当前的位置:
首页 >
文章列表页 >
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
- MMR 2024年11卷第3期 页码:345-373
DOI: 10.1186/s40779-023-00468-6
移动端阅览
HTML全文
图( 8 ) 表( 6 )
参考文献
出版信息
数据统计
31
浏览量
21
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
CRISPR/Cas9 from bench to bedside: What clinicians need to know before application?
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Engineering of functional auditory neurons from human induced pluripotent stem cells
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
相关作者
Zi-Qing Li
Chao-Hong Li
相关机构
Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University
Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania
Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University

